Medicenna Therapeutics GAAP EPS of -C$0.05

Seeking Alpha11/15 23:55

Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO) and the 2024 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire11/13 20:00

Medicenna Announces Positive Single-Agent Activity of MDNA11 From Dose Expansion Cohort and Encouraging Safety Profile in Combination With KEYTRUDA (Pembrolizumab) at the 39th Annual Meeting of SITC

GlobeNewswire11/11 20:00

Bloom Burton & Co.はMedicenna Therapeutics(MDNAF.US)のレーティングを強気に据え置き、目標株価を6ドルに据え置いた

Bloom Burton & Co.のアナリストDavid Martin PhDは$Medicenna Therapeutics(MDNAF.US)$のレーティングを強気に据え置き、目標株価を6ドルに据え置いた。TipRanksのデータによると、このアナリストの最近1年間の的中率は45.7%、平均リターンは26.7%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率お

Futuニュース11/11 16:35

OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX

GlobeNewswire10/15 19:00

Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire10/04 21:07